Title |
Searching Synergistic Dose Combinations for Anticancer Drugs
|
---|---|
Published in |
Frontiers in Pharmacology, May 2018
|
DOI | 10.3389/fphar.2018.00535 |
Pubmed ID | |
Authors |
Zuojing Yin, Zeliang Deng, Wenyan Zhao, Zhiwei Cao |
Abstract |
Recent development has enabled synergistic drugs in treating a wide range of cancers. Being highly context-dependent, however, identification of successful ones often requires screening of combinational dose on different testing platforms in order to gain the best anticancer effects. To facilitate the development of effective computational models, we reviewed the latest strategy in searching optimal dose combination from three perspectives: (1) mainly experimental-based approach; (2) Computational-guided experimental approach; and (3) mainly computational-based approach. In addition to the introduction of each strategy, critical discussion of their advantages and disadvantages were also included, with a strong focus on the current applications and future improvements. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 34 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 5 | 15% |
Student > Ph. D. Student | 5 | 15% |
Student > Bachelor | 4 | 12% |
Student > Master | 4 | 12% |
Other | 3 | 9% |
Other | 5 | 15% |
Unknown | 8 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 5 | 15% |
Chemistry | 5 | 15% |
Medicine and Dentistry | 4 | 12% |
Engineering | 2 | 6% |
Agricultural and Biological Sciences | 2 | 6% |
Other | 7 | 21% |
Unknown | 9 | 26% |